Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Apple
AAPL
|
$744M |
| 2 |
Merck
MRK
|
$570M |
| 3 |
GoDaddy
GDDY
|
$352M |
| 4 |
CSX Corp
CSX
|
$235M |
| 5 |
Edwards Lifesciences
EW
|
$235M |
Top Sells
| 1 |
DexCom
DXCM
|
$391M |
| 2 |
Biogen
BIIB
|
$382M |
| 3 |
Broadcom
AVGO
|
$353M |
| 4 |
Adobe
ADBE
|
$293M |
| 5 |
Union Pacific
UNP
|
$264M |
Sector Composition
| 1 | Technology | 24.39% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.84% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Abbott
ABT
$229B
| $1B | 0.54% |
13,678,979
-29,193
| -0.2% | -$2.14M |
|
27
Eli Lilly
LLY
$659B
| $983M | 0.53% |
9,163,495
-845,273
| -8% | -$90.7M |
|
28
Intuitive Surgical
ISRG
$168B
| $974M | 0.52% |
1,697,179
-132,744
| -7% | -$76.2M |
|
29
UnitedHealth
UNH
$280B
| $967M | 0.52% |
3,635,040
+109,950
| +3% | +$29.3M |
|
|
ULTI
30
DELISTED
Ultimate Software Group Inc
ULTI
| $966M | 0.52% |
2,999,361
-226,458
| -7% | -$73M |
|
31
Microchip Technology
MCHP
$34.3B
| $957M | 0.51% |
12,125,949
-793,656
| -6% | -$62.6M |
|
|
CELG
32
DELISTED
Celgene Corp
CELG
| $936M | 0.5% |
10,461,658
+1,391,617
| +15% | +$125M |
|
|
33
CSX Corp
CSX
$60B
| $933M | 0.5% |
12,600,194
+3,178,806
| +34% | +$235M |
|
34
Intercontinental Exchange
ICE
$100B
| $914M | 0.49% |
12,202,306
+666,185
| +6% | +$49.9M |
|
35
Progressive
PGR
$144B
| $885M | 0.47% |
12,457,383
+361,810
| +3% | +$25.7M |
|
36
Neurocrine Biosciences
NBIX
$14.1B
| $881M | 0.47% |
7,162,465
-252,396
| -3% | -$31M |
|
37
Alphabet (Google) Class A
GOOGL
$2.56T
| $860M | 0.46% |
711,959
+27,550
| +4% | +$33.3M |
|
|
TMX
38
DELISTED
Terminix Global Holdings, Inc.
TMX
| $854M | 0.46% |
13,760,322
+103,547
| +0.8% | +$6.42M |
|
39
Steris
STE
$23.8B
| $851M | 0.45% |
7,437,198
-131,458
| -2% | -$15M |
|
40
Gartner
IT
$19B
| $846M | 0.45% |
5,339,576
+100,882
| +2% | +$16M |
|
|
AGN
41
DELISTED
Allergan plc
AGN
| $825M | 0.44% |
4,328,872
-449,827
| -9% | -$85.7M |
|
42
Lam Research
LRCX
$123B
| $817M | 0.44% |
5,388,030
-115,825
| -2% | -$17.6M |
|
43
Broadridge
BR
$29.5B
| $817M | 0.44% |
6,193,580
+77,517
| +1% | +$10.2M |
|
44
Bank of America
BAC
$373B
| $811M | 0.43% |
27,529,779
-126,188
| -0.5% | -$3.72M |
|
45
Home Depot
HD
$404B
| $797M | 0.43% |
3,846,265
+75,918
| +2% | +$15.7M |
|
46
WEX
WEX
$5.79B
| $773M | 0.41% |
3,847,890
-119,436
| -3% | -$24M |
|
47
Estee Lauder
EL
$32.7B
| $747M | 0.4% |
5,143,117
+701,827
| +16% | +$102M |
|
48
Coca-Cola
KO
$297B
| $734M | 0.39% |
15,897,330
-25,790
| -0.2% | -$1.19M |
|
49
Crown Castle
CCI
$42.7B
| $734M | 0.39% |
6,595,096
-12,045
| -0.2% | -$1.34M |
|
50
Cooper Companies
COO
$13B
| $726M | 0.39% |
2,618,064
-626
| -0% | -$173K |
|